Back
Bunge Global SA 10K Form
Sell
43
BG
Bunge Global SA
Last Price:
89.73
Seasonality Move:
5.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-08-09 | 10Q | BG/Bunge Global SA Quarterly |
2023-05-03 | 10Q | BG/Bunge Global SA Quarterly |
2022-10-26 | 10Q | BG/Bunge Global SA Quarterly |
2022-07-27 | 10Q | BG/Bunge Global SA Quarterly |
2022-04-27 | 10Q | BG/Bunge Global SA Quarterly |
2021-10-27 | 10Q | BG/Bunge Global SA Quarterly |
Receive BG News And Ratings
See the #1 stock for the next 7 days that we like better than BG
BG Financial Statistics
Sales & Book Value
Annual Sales: | $59.54B |
---|---|
Cash Flow: | $973M |
Price / Cash Flow: | 11.89 |
Annual Sales: | $72.59 |
Price / Book: | 1.24 |
Profitability
EPS (TTM): | 7.88000 |
---|---|
Net Income (TTM): | $1.15B |
Gross Margin: | $4.85B |
Return on Equity: | 10.16% |
Return on Assets: | 4.57% |
Bunge Global SA Earnings Forecast
Key Bunge Global SA Financial Ratios
- The Gross Profit Margin over the past 25 years for BG is 8.14%.
- The Selling, General & Administrative Expenses for BG have been equal to 2.88% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 23.00% of Operating Income.
- The Net Earning history of BG is 3.77% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 16 years.
Bunge Global SA Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Food Products |
Sector: | Consumer Staples |
Current Symbol: | BG |
CUSIP: | G16962 |
Website: | bunge.com |
Debt
Debt-to-Equity Ratio: | 0.61 |
---|---|
Current Ratio: | 2.07 |
Quick Ratio: | 0.72 |
Price-to-Earnings
Trailing P/E Ratio: | 6.04 |
---|---|
Forward P/E Ratio: | 9.74 |
BG Technical Analysis vs Fundamental Analysis
Sell
43
Bunge Global SA (BG)
is a Sell
Is Bunge Global SA a Buy or a Sell?
-
Bunge Global SA stock is rated a Sell
The current Bunge Global SA [BG] share price is $89.74. The Score for BG is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.